U.S., March 21 -- ClinicalTrials.gov registry received information related to the study (NCT06885736) titled 'LEAN Mass Preservation with Resistance Exercise and Protein During Semaglutide/Tirzepatide Therapy' on March 09.
Brief Summary: The aim of the current study is to determine whether resistance exercise and/or protein intake can preserve lean mass and improve physical function in patients with type 2 diabetes initiating semaglutide/tirzepatide therapy. To achieve this aim the study will have the following objectives.
In people with type 2 diabetes initiating semaglutide/tirzepatide therapy
1. Form a PPI group to refine the study protocol and establish study materials,
2. Quantify the effects of a pragmatic resistance exercise inte...